Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder

被引:33
作者
Karpinski, Pawel [1 ]
Frydecka, Dorota [2 ]
Sasiadek, Maria M. [1 ]
Misiak, Blazej [1 ,2 ]
机构
[1] Wroclaw Med Univ, Dept Genet, 1 Marcinkowski St, PL-50368 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Psychiat, 10 Pasteur St, PL-50367 Wroclaw, Poland
关键词
Lymphocytes; NK cells; Computational deconvolution; Inflammation; Immunity; Schizophrenia; Bipolar disorder; ACUTE-PHASE PROTEINS; RNA-QUALITY; NK CELLS; T-CELLS; EXPRESSION DATA; GENECHIP DATA; BLOOD; ACTIVATION; CYTOKINES; IMMUNE;
D O I
10.1016/j.bbi.2016.02.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Overwhelming evidence indicates that subthreshold inflammatory state might be implicated in the pathophysiology of schizophrenia (SCZ) and bipolar disorder (BPD). It has been reported that both groups of patients might be characterized by abnormal lymphocyte counts. However, little is known about alterations in lymphocyte proportions that may differentiate SCZ and BPD patients. Therefore, in this study we investigated blood cell proportions quantified by means of microarray expression deconvolution using publicly available data from SCZ and BPD patients. We found significantly lower counts of natural killer (NK) cells in drug-naive and medicated SCZ patients compared to healthy controls across all datasets. In one dataset from SCZ patients, there were no significant differences in the number of NK cells between acutely relapsed and remitted SCZ patients. No significant difference in the number of NK cells between BPD patients and healthy controls was observed in all datasets. Our results indicate that SCZ patients, but not BPD patients, might be characterized by reduced counts of NK cells. Future studies looking at lymphocyte counts in SCZ should combine the analysis of data obtained using computational deconvolution and flow cytometry techniques. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 67 条
[1]   Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus [J].
Abbas, Alexander R. ;
Wolslegel, Kristen ;
Seshasayee, Dhaya ;
Modrusan, Zora ;
Clark, Hilary F. .
PLOS ONE, 2009, 4 (07)
[2]  
Abeer, 2006, Egypt J Immunol, V13, P79
[3]  
[Anonymous], SCHIZOPHR RES
[4]   Monocyte and Lymphocyte Activation in Bipolar Disorder: A New Piece in the Puzzle of Immune Dysfunction in Mood Disorders [J].
Barbosa, Izabela Guimaraes ;
Rocha, Natlia Pessoa ;
Assis, Frankcineia ;
Marciano Vieira, Erica Leandro ;
Soares, Jair C. ;
Bauer, Moises Evandro ;
Teixeira, Antonio Lucio .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (01)
[5]   NCBI GEO: archive for functional genomics data sets-update [J].
Barrett, Tanya ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Evangelista, Carlos ;
Kim, Irene F. ;
Tomashevsky, Maxim ;
Marshall, Kimberly A. ;
Phillippy, Katherine H. ;
Sherman, Patti M. ;
Holko, Michelle ;
Yefanov, Andrey ;
Lee, Hyeseung ;
Zhang, Naigong ;
Robertson, Cynthia L. ;
Serova, Nadezhda ;
Davis, Sean ;
Soboleva, Alexandra .
NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D991-D995
[6]   The influence of olanzapine on immune cells in patients with schizophrenia [J].
Bilici, M ;
Tekelioglu, Y ;
Efendioglu, S ;
Ovali, E ;
Ülgen, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (03) :483-485
[7]   Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia [J].
Brambilla, P. ;
Bellani, M. ;
Isola, M. ;
Bergami, A. ;
Marinelli, V. ;
Dusi, N. ;
Rambaldelli, G. ;
Tansella, M. ;
Finardi, A. Maria ;
Martino, G. ;
Perlini, C. ;
Furlan, R. .
TRANSLATIONAL PSYCHIATRY, 2014, 4 :e406-e406
[8]   High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder [J].
Breunis, MN ;
Kupka, RW ;
Nolen, WA ;
Suppes, T ;
Denicoff, KD ;
Leverich, GS ;
Post, RM ;
Drexhage, HA .
BIOLOGICAL PSYCHIATRY, 2003, 53 (02) :157-165
[9]  
Bukowska-Straková K, 2006, FOLIA HISTOCHEM CYTO, V44, P179
[10]   Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile [J].
Clelland, Catherine L. ;
Read, Laura L. ;
Panek, Laura J. ;
Nadrich, Robert H. ;
Bancroft, Carter ;
Clelland, James D. .
PLOS ONE, 2013, 8 (06)